BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21085822)

  • 1. Dyspnea in COPD: beyond the modified Medical Research Council scale.
    Camargo LA; Pereira CA
    J Bras Pneumol; 2010; 36(5):571-8. PubMed ID: 21085822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment tests in evaluating patients with chronic obstructive pulmonary disease: A cross-sectional study.
    Chuang ML; Lin IF; Lee CY
    Medicine (Baltimore); 2016 Nov; 95(47):e5471. PubMed ID: 27893695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between small airway function, ventilation distribution, and functional exercise capacity in COPD patients.
    Lopes AJ; Mafort TT
    Lung; 2014 Oct; 192(5):653-9. PubMed ID: 25047513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease.
    Chhabra SK; Gupta AK; Khuma MZ
    Ann Thorac Med; 2009 Jul; 4(3):128-32. PubMed ID: 19641643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor analysis of laboratory and clinical measurements of dyspnea in patients with chronic obstructive pulmonary disease.
    Nguyen HQ; Altinger J; Carrieri-Kohlman V; Gormley JM; Stulbarg MS
    J Pain Symptom Manage; 2003 Feb; 25(2):118-27. PubMed ID: 12590027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD.
    Al-Shair K; Kolsum U; Singh D; Vestbo J
    Lung; 2016 Dec; 194(6):889-895. PubMed ID: 27549363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.
    Oga T; Tsukino M; Hajiro T; Ikeda A; Nishimura K
    Respir Res; 2012 Sep; 13(1):85. PubMed ID: 23006638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD.
    Al-shair K; Dockry R; Mallia-Milanes B; Kolsum U; Singh D; Vestbo J
    Respir Med; 2009 Oct; 103(10):1572-9. PubMed ID: 19560330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the BODE index correlate with quality of life in patients with COPD?
    Araujo ZT; Holanda G
    J Bras Pneumol; 2010; 36(4):447-52. PubMed ID: 20835591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inspiratory capacity, exercise limitation, markers of severity, and prognostic factors in chronic obstructive pulmonary disease.
    Freitas CG; Pereira CA; Viegas CA
    J Bras Pneumol; 2007; 33(4):389-96. PubMed ID: 17982530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
    Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the human activity profile, a functional performance measure, in people with chronic obstructive pulmonary disease.
    Nield M; Hoo GS; Roper J; Santiago S; Dracup K
    J Cardiopulm Rehabil; 2005; 25(2):115-21. PubMed ID: 15818201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI).
    Obi ON; Judson MA; Birring SS; Maier LA; Wells AU; Lower EE; Baughman RP
    Respir Med; 2022 Jan; 191():106436. PubMed ID: 33992496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of dyspnea and dynamic hyperinflation in male patients with chronic obstructive pulmonary disease during a six minute walk test and an incremental treadmill cardiorespiratory exercise test.
    Alfonso M; Bustamante V; Cebollero P; Antón M; Herrero S; Gáldiz JB
    Rev Port Pneumol (2006); 2017; 23(5):266-272. PubMed ID: 28579149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.
    Worth H; Förster K; Eriksson G; Nihlén U; Peterson S; Magnussen H
    Respir Med; 2010 Oct; 104(10):1450-9. PubMed ID: 20692140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD.
    Ramon MA; Ferrer J; Gimeno-Santos E; Donaire-Gonzalez D; Rodríguez E; Balcells E; de Batlle J; Benet M; Guerra S; Sauleda J; Ferrer A; Farrero E; Gea J; Barberà JA; Agustí A; Rodriguez-Roisin R; Antó JM; Garcia-Aymerich J;
    Respirology; 2016 Apr; 21(3):476-82. PubMed ID: 26714424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD.
    de Torres JP; Pinto-Plata V; Ingenito E; Bagley P; Gray A; Berger R; Celli B
    Chest; 2002 Apr; 121(4):1092-8. PubMed ID: 11948037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the culturally adapted oxygen-cost diagram in the assessment of dyspnea in Puerto Rico.
    De Jesús-Berrios Y; Santos-Rodríguez RA; Dexter D; Nieves-Plaza M; Nazario CM
    P R Health Sci J; 2015 Mar; 34(1):14-9. PubMed ID: 25856872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.